|
HEATR5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.989500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.623300E-03 |
| Normal-vs-Stage2 |
6.0455999999931E-05 |
| Normal-vs-Stage3 |
2.804200E-04 |
| Normal-vs-Stage4 |
4.436800E-03 |
| Stage1-vs-Stage2 |
1.060500E-02 |
| Stage1-vs-Stage3 |
4.633700E-02 |
| Stage1-vs-Stage4 |
4.034600E-01 |
| Stage2-vs-Stage3 |
3.174200E-01 |
| Stage2-vs-Stage4 |
1.085220E-01 |
| Stage3-vs-Stage4 |
4.376800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.004000E-04 |
| Normal-vs-AfricanAmerican |
2.504200E-01 |
| Normal-vs-Asian |
2.314000E-01 |
| Caucasian-vs-AfricanAmerican |
2.141400E-01 |
| Caucasian-vs-Asian |
4.371500E-02 |
| AfricanAmerican-vs-Asian |
8.192600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.322460E-03 |
| Normal-vs-Female |
5.405900E-04 |
| Male-vs-Female |
7.590400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.158300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.190600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.206130E-04 |
| Normal-vs-Age(81-100Yrs) |
6.721400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.112770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.441600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.813970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.615600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.118800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.083400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.074400E-01 |
| Classical-VS-Follicular |
5.077500E-03 |
| Classical-VS-Other |
7.752600E-01 |
| Classical-VS-Normal |
2.349800E-02 |
| Tall-VS-Follicular |
1.348160E-01 |
| Tall-VS-Other |
5.751200E-01 |
| Tall-VS-Normal |
3.773900E-02 |
| Follicular-VS-Other |
2.611200E-01 |
| Follicular-VS-Normal |
7.8809000000013E-05 |
| Other-VS-Normal |
5.007400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.94540000000953E-06 |
| Normal-vs-N1 |
1.538100E-02 |
| N0-vs-N1 |
2.505800E-01 |
|
|
